视网膜微血管口径与肾功能下降关联的系统综述与个体参与者荟萃分析
聚合分析纳入11项研究44803例,个体分析纳入9项研究33222例,CKD 3-5期患病率分别为11.3%和11.2%。校正分析中,视网膜小动脉与小静脉口径每降低20 μm均未显示与CKD 3-5期显著相关。
要点
- 视网膜小动脉口径降低20 μm与CKD 3-5期无显著关联(RR 0.98)。
- 视网膜小静脉口径降低20 μm与CKD 3-5期无显著关联(RR 0.99)。
- 提示横断面视网膜血管口径测量对CKD 3-5期筛查价值有限。
核心结论
- 荟萃分析证据不足以支持视网膜血管口径的直接测量与普通人群CKD 3-5期存在横断面关联。
- 建议今后开展纵向研究荟萃分析,评估视网膜参数与CKD 3-5期的关联。
研究设计与样本
- 聚合数据荟萃分析采用两阶段法,合并11项研究共44803例患者的汇总估计。
- 个体参与者数据荟萃分析采用一阶段法,合并9项研究共33222例患者的原始数据。
- CKD 3-5期定义为估算肾小球滤过率低于60 mL/min/1.73m2。
- 视网膜小动脉与小静脉口径(中央视网膜小动脉当量和小静脉当量)通过计算机辅助方法从视网膜照片评估。
主要发现
- CKD 3-5期患病率在个体参与者分析33222例中为11.2%,在聚合分析44803例中为11.3%。
- 聚合分析校正后中央视网膜小动脉当量相对风险0.98(95%CI 0.94-1.03),小静脉当量0.99(0.95-1.04)。
- 个体参与者分析校正后中央视网膜小动脉当量0.99(0.95-1.04),小静脉当量1.01(0.97-1.05)。
关键数值与推荐
- 暴露为中央视网膜小动脉当量和小静脉当量每降低20 μm(约一个标准差)。
- 结局为CKD 3-5期,采用logistic回归估计相对风险。
- 校正分析中各关联的95%CI均跨越1,无统计学显著性。
临床怎么用
- 横断面视网膜血管口径测量不宜作为普通人群CKD 3-5期的筛查或风险评估工具。
- 视网膜微血管改变与肾功能下降的关联仍需纵向研究进一步验证。
局限性
- 研究为横断面设计,无法推断视网膜血管口径与CKD 3-5期的时序或因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Previously, variation in retinal vascular caliber has been reported in association with chronic kidney disease (CKD) but findings remain inconsistent. To help clarify this we conducted individual participant data meta-analysis and aggregate data meta-analysis on summary estimates to evaluate cross-sectional associations between retinal vascular caliber and CKD. A systematic review was performed using Medline and EMBASE for articles published until October 2018. The aggregate analysis used a two-stage approach combining summary estimates from eleven studies (44,803 patients) while the individual participant analysis used a one-stage approach combining raw data from nine studies (33,222 patients). CKD stages 3-5 was defined as an estimated glomerular filtration rate under 60 mL/min/1.73m2. Retinal arteriolar and venular caliber (central retinal arteriolar and venular equivalent) were assessed from retinal photographs using computer-assisted methods. Logistic regression estimated relative risk of CKD stages 3-5 associated with a 20 μm decrease (approximately one standard deviation) in central retinal arteriolar and venular equivalent. Prevalence of CKD stages 3-5 was 11.2% of 33,222 and 11.3% of 44,803 patients in the individual participant and aggregate data analysis, respectively. No significant associations were detected in adjusted analyses between central retinal arteriolar and venular equivalent and CKD stages 3-5 in the aggregate analysis for central retinal arteriolar relative risk (0.98, 95% confidence interval 0.94-1.03); venular equivalent (0.99, 0.95-1.04) or individual participant central retinal arteriolar (0.99, 0.95-1.04) or venular equivalent (1.01, 0.97-1.05). Thus, meta-analysis provided little evidence to suggest that cross sectional direct measurements of retinal vascular caliber was associated with CKD stages 3-5 in the general population. Hence, meta-analyses of longitudinal studies evaluating the association between retinal parameters and CKD stages 3-5 may be warranted.
引用
- Lye WK, Paterson E, Patterson CC, et al. A systematic review and participant-level meta-analysis found little association of retinal microvascular caliber with reduced kidney function. Kidney Int. 2020. PMID: 32810524. doi:10.1016/j.kint.2020.06.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。